{
  "N/R/U": null,
  "Applicant": "Janssen Biotech, Inc.",
  "BLA Number": "125746",
  "Proprietary Name": "Carvykti",
  "Proper Name": "ciltacabtagene autoleucel",
  "BLA Type": "351(a)",
  "Strength": "0.5 to 1.0x10^6 chimeric antigen receptor (CAR)-positive viable T cells per kg of body weight, with a maximum dose of 1x10^8 CAR-positive viable T cells in one infusion",
  "Dosage Form": "For Injection",
  "Route of Administration": "Intravenous",
  "Product Presentation": "Bag",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "28-Feb-22",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": "0",
  "Submission Type": "Original",
  "License Number": "1864",
  "Product Number": "1",
  "Center": "CBER",
  "Date of First Licensure": "28-Feb-22",
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": "28-Feb-34",
  "Orphan Exclusivity Exp. Date": "5-Apr-31"
}